{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to mskcc.org Home
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand Courses
  • Gift Certificates
  • About
  • Visiting Us
  • Contact
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Sign in (MSK Employees Only)
Sign in or Create an Account (Non-MSK Employee)
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

1st Annual Symposium on Advanced Therapeutics for Brain Metastasis: Moving the Needle and Controversies at the Cutting Edge


1st Annual Symposium on Advanced Therapeutics for Brain Metastasis: Moving the Needle and Controversies at the Cutting Edge Banner

  • Overview
  • Register
  • Faculty
  • Brochure
Add to Calendar 1st Annual Symposium on Advanced Therapeutics for Brain Metastasis: Moving the Needle and Controversies at the Cutting Edge 3/3/2023 8:00:00 AM 3/3/2023 5:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?P=0&EID=36282 Description: This course will provide an update on the latest developments in the treatment and research of brain metastasis, with a focus on CNS-specific outcomes from both molecular and traditional cancer histology viewpoints. Online false MM/DD/YYYY


Date & Location
Friday, March 3, 2023, 8:00 AM - 5:00 PM, Online, New York, NY

Specialties
Specialties - Breast Medical Oncology, Genitourinary Oncology, Gynecologic Oncology, Medical Oncology, Neuro-Oncology, Neuroradiology, Neurosurgery, Oncology and Hematology, Radiation Oncology, Solid Tumor Oncology, Thoracic Medical Oncology

Overview

This complimentary virtual symposium will provide clinicians and translational scientists with updates on the latest developments in brain metastasis treatment and research, CNS-specific outcomes from molecular and traditional cancer histology viewpoints. Recent evidence for brain metastasis activity will be highlighted for key medical targets (e.g. Her2, EGFR, KRAS, CDK, BRAF, and ALK), and leading experts will review brain metastasis prognosis across the cancers commonly resulting in this (lung, breast, and melanoma).

Highlights of this didactic and case-based program include:

  • Sessions on the recent developments in local therapy, a review of the role of laser interstitial thermal therapy, brachytherapy, and external beam radiation techniques.
  • In recognition of the many complex treatment interactions imposed by multimodality treatment often necessary, a 'Key Controversies' session will speak to major areas of clinical difficulty; for example: how to distinguish the recurrent disease from radiation necrosis on imaging studies, when to change therapy with CNS-only progressive disease, which leptomeningeal metastasis interventions are currently worthwhile, and special considerations regarding steroid use and radiation therapy for patients requiring immunotherapy.
  • Key scientists will discuss promising translational and clinical trial approaches including targeting metastasis-initiating cells and window-of-opportunity studies.
  • Given the special challenge of early detection, a dedicated session will cover state-of-the-art molecular imaging techniques, the evidence for/against imaging surveillance in standard-risk cancers, and the current state of liquid biopsy.
  • A roundtable discussion with participants from several centers will share their experiences and best practices with multidisciplinary team care and discuss areas for improvement.
  • Finally, a multidisciplinary tumor board will review multifaceted cases, highlighting the interplay of various treatment options.

There will be ample opportunity for networking with speakers and other participants in this virtual meeting.

Who Should Attend

This symposium is intended for neurosurgeons, radiation oncologists, neurologists and neuro-oncologists, physicians in training, and other allied health professionals who treat and manage patients with metastatic disease.


Objectives
  1. Describe the current multimodal landscape of brain metastasis treatment
  2. Identify key clinical controversies in brain metastasis management
  3. Discuss barriers to improved treatments and potential research strategies (e.g. limited CNS activity of systemic anti-cancer treatments, side effects of local treatments, limited survival, and unclear endpoints)

Registration

This symposium is complimentary. Please complete registration through the 'Register' tab above in order to attend (registration is required). 

Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help

If you are registered for this symposium and unable to attend, please email [email protected] to cancel your registration.

Live Virtual Format

This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.

Detailed access instructions will be emailed to registered attendees prior to the start of the program. 


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

 

This complimentary virtual Symposium will answer many questions on the latest developments in the treatment and research of brain metastasis, such as:



Keywords: ComplimentaryLive VirtualAMA PRA Category 1



MSK Symposium Director

Nelson Moss, MD
Co-Director, Multidisciplinary Brain Metastasis Program
Assistant Attending
Department of Neurosurgery

 

MSK Symposium Co-Director 

Adrienne A. Boire, MD, PhD
Geoffrey Beene Junior Faculty Chair
Assistant Attending
Brain Tumor Service 
Department of Neurology 

 

Invited Faculty

Kathryn Beal, MD
Radiation Oncologist 

Priscilla Brastianos, MD
Director, Central Nervous System Metastasis Program
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital

Veronica Chiang, MD
Professor, Yale University School of Medicine
Departments of Neurosurgery and Therapeutic Radiology
Assistant Dean for MD Admissions, Yale University School of Medicine
Vice-Chair of Academic Affairs, Dept of Neurosurgery
Director, Yale New Haven Hospital Gamma Knife Program
Director, Yale Multidisciplinary Brain Metastasis Program

Michael Davies, MD, PhD
Professor and Chair, Department of Melanoma Medical Oncology
Professor, Translational Molecular Pathology, Genomic Medicine, Systems Biology
Anne and John Mendelsohn Chair in Cancer Research
The University of Texas MD Anderson Cancer Center

Peter Fecci, MD
Director, Duke Center for Brain and Spine Metastasis
Director, Brain Tumor Immunotherapy Program
Director, Surgical Neuro-oncology
Duke Cancer Center

Nancy Lin, MD
Associate Chief, Division of Breast Oncology, Susan F. Smith Center for Women's Cancers
Director, Metastatic Breast Cancer Program
Director, Program for Patients with Breast Cancer Brain Metastases
Senior Physician
Associate Professor of Medicine, Harvard Medical School

Sarah Sammons, MD
Associate Director, Metastatic Breast Cancer Program
Dana-Farber Cancer Institute

Hussein Tawbi, MD, PhD
Deputy Chair, Department of Melanoma Medical Oncology
Co-Director, MD Anderson Brain Metastasis Clinic
The University of Texas MD Anderson Cancer Center

Manuel Valiente, PhD
Principal Investigator
CNIO

Min Yu, MD, PhD
Associate Professor, Department of Pharmacology
University of Maryland School of Medicine

 

MSK Faculty 

Brandon Imber, MD, MA
Assistant Attending, Department of Radiation Oncology 

Bob T. Li, MD, PhD, MPH
Physician Ambassador to China and Asia-Pacific, Bobst International Center
Co-Director, Thoracic Liquid Biopsy Program
Chief Scientific Officer, MSK Direct
Associate Attending, Department of Medicine  

Luke R.G. Pike, MD, DPhil
Assistant Attending, Department of Radiation Oncology  

Pedram Razavi, MD, PhD
Director of Liquid Biopsy Technologies & Genomics
Assistant Attending, Department of Medicine  

Gregory J. Riely, MD, PhD
Vice Chair of Clinical Research
Attending, Department of Medicine  

Andrew D. Seidman, MD
Attending, Department of Medicine  

Viviane Tabar, MD
Chair, Department of Neurosurgery
Theresa Feng Chair in Neurosurgical Oncology

Jessica A. Wilcox, MD
Assistant Attending, Department of Neurology 

Randy Yeh, MD
Assistant Attending, Department of Radiology 

Robert J. Young, MD
Director, 3T Neuroradiology Imaging
Attending, Department of Radiology 



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.



Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Adrienne Boire, MD, PhD
MSK
Activity Co-Director, Conflict of Interest Peer Reviewer, Faculty
Nothing to disclose
Nelson Moss, MD
MSK
Activity Director, Faculty
Consulting Fee-AstraZeneca|Grant or research support-GT Medical Technologies|Grant or research support-AstraZeneca
Shahiba Q Ogilvie, MPH
MSK
Department Support (manager, assistant, etc)
Nothing to disclose
Kathryn Beal, MD

Faculty
Board of Directors Member-Magnolia Medical Technologies
Priscilla Brastianos, MD
Harvard Medical School
Faculty
Veronica Chiang, MD
Yale University School of Medicine
Faculty
Consulting Fee-Monteris Medical inc
Michael Davies, MD, PhD
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Roche|Consulting Fee-Array (Relationship has ended)|Consulting Fee-Novartis AG|Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-Iovance|Consulting Fee-Merck and Company, Inc.|Advisor-ABM Therapeutics|Grant or research support-ABM Therapeutics|Grant or research support-Lead Pharma
Peter Fecci, MD
Duke Cancer Center
Faculty
Consulting Fee-Monteris Medical, LLC
Brandon Imber, MD
MSK
Faculty
Honoraria-GT Medical Technologies (Relationship has ended)
Bob T. Li, MD
MSK
Faculty
Grant or research support-Amgen|Grant or research support-AstraZeneca|Grant or research support-Daiichi Sankyo|Grant or research support-Eli Lilly and Company|Grant or research support-Hengrui USA|Grant or research support-Bolt Biotherapeutics|Grant or research support-Genentech, Inc.
Nancy Lin, MD
Harvard Medical School
Faculty
Advisor-SeaGen|Advisor-AstraZeneca|Consulting Fee-Prelude Therapeutics|Consulting Fee-Olema Pharmaceuticals|Consulting Fee-Blueprint Medicines|Consulting Fee-Johnson and Johnson|Grant or research support-AstraZeneca|Grant or research support-Genentech, Inc.|Grant or research support-Pfizer, Inc.|Grant or research support-SeaGen|Grant or research support-Zion Pharmaceuticals|Grant or research support-Olema Pharmaceuticals|Advisor-Artera Inc
Luke R. G. Pike, MD, DPHIL
Memorial Sloan Kettering Cancer Center
Faculty
Consulting Fee-Aviko Inc|Consulting Fee-Monograph Capital|Consulting Fee-Turnstone Biologics|Consulting Fee-Monte Rosa Therapeutics|Stocks or stock options, excluding diversified mutual funds-Clovis Therapeutics|Grant or research support-Delfi Diagnostics|Grant or research support-Varian
Pedram Razavi, MD, PhD
MSK
Faculty
Advisor-Tempus|Grant or research support-AstraZeneca|Advisor-Novartis AG (Relationship has ended)|Grant or research support-AstraZeneca|Advisor-Foundation Medicine (Relationship has ended)|Advisor-Natera (Relationship has ended)|Grant or research support-Inivata|Grant or research support-Grail/Illumina|Grant or research support-Invitae/ArcherDx|Grant or research support-Epic Sciences|Grant or research support-Novartis AG|Grant or research support-Guardant|Advisor-Paige.AI|Advisor-Guardant|Board of Directors Member-Odyssey Biosciences|Grant or research support-Biovica|Advisor-SAGA Diagnostics
Gregory Riely, MD
MSK
Faculty
Sarah Sammons, MD
Dana-Farber Cancer Institute
Faculty
Andrew D Seidman, MD
MSK
Faculty
Consulting Fee-Genentech, Inc.|Honoraria-Genentech, Inc.|Consulting Fee-Gilead|Honoraria-Gilead|Consulting Fee-Eli Lilly and Company|Honoraria-Eli Lilly and Company|Consulting Fee-Novartis AG|Honoraria-Novartis AG|Consulting Fee-Pfizer, Inc. (Relationship has ended)|Honoraria-Pfizer, Inc. (Relationship has ended)|Advisor-Osmol Therapeutics|Advisor-Samus (Relationship has ended)|Consulting Fee-BeyondSpring (Relationship has ended)|Consulting Fee-Athenex (Relationship has ended)|Honoraria-AstraZeneca|Honoraria-Immunomedics (Relationship has ended)|Consulting Fee-Daiichi Sankyo (Relationship has ended)|Honoraria-Stemline Therapeutics
Viviane Tabar, MD
MSK
Faculty
Advisor-BlueRock Therapeutics
Hussein Tawbi, MD, PhD
The University of Texas MD Anderson Cancer Center
Faculty
Manuel Valiente, PhD
CNIO
Faculty
Nothing to disclose
Jessica Wilcox, MD
MSK
Faculty
Nothing to disclose
Randy Yeh, MD
MSK
Faculty
Nothing to disclose
Robert Young, MD
MSK
Faculty
Consulting Fee-ICON plc
Min Yu, MD, PhD
Keck School of Medicine of USC
Faculty
Ownership-CanTraCer Biosciences Inc.

MSK CME LINKS

Live Courses
On Demand Courses
Visiting Us
About MSK CME
Contact
Help

ATTENDEE & FACULTY RESOURCES

Course Resources (My CME)
Claim CME Credit for a Live Course
Claim CME Credit for a RSS (MSK employees only)
MSK CME Disclosure Form
MSK CME Faculty Forms

STAY CONNECTED WITH US

Follow MSK CME on Twitter
Like MSK CME on Facebook
Join MSK CME on LinkedIn
Subscribe to MSK CME Course Announcements



MSK CME

mskcc.org | Legal Disclaimer | Privacy Practices | Public Notices
© 2023 Memorial Sloan Kettering Cancer Center